||||
Lipoatrophy caused by injected drug (disorder)
Lipoatrophy due to injected drug
Lipoatrophy caused by injected drug
Drug-induced localized lipoatrophy
A rare localized lipodystrophy characterized by the appearance of asymptomatic, well-demarcated, variably sized, depressed, lipoatrophic lesions secondary to subcutaneous, intradermic or intramuscular drug injection, including corticosteroids, insulin, human growth hormone and antibiotics. Skin coloration may vary from white or hypopigmented to reddish, pinkish or violaceous. Epidermal atrophy may be also present.
lipoatrofie door geïnjecteerde medicatie
lipoatrofie door injectie van geneesmiddel
Id403661001
StatusDefined
Associated morphologyAtrophy
Causative agentDrug or medicament
Finding siteSubcutaneous fatty tissue
DHD Diagnosis thesaurus reference set
ICD-10 complex map reference set
TargetE88.1
RuleTRUE
AdviceALWAYS E88.1 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION | POSSIBLE REQUIREMENT FOR AN EXTERNAL CAUSE CODE
CorrelationSNOMED CT source code to target map code correlation not specified
|